Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the overall response rate to Iressa as a first-line
treatment in chemonaive patients with inoperable Non-Small Cell Lung Cancer (NSCLC)